Share

09 May 2021 For the moment, the European Commission has not renewed its contract for the anti-covid vaccines developed by AstraZeneca beyond the expiration of the current contract, which is expected at the end of June.

This was stated by European Internal Trade Commissioner Thierry Breton on France Inter.

"We have not renewed the order after June - he stressed -. We will see what happens". 



In recent weeks, a lawsuit has been filed against the Anglo-Swedish company for breach of the contract. 



Speaking to France inter, Breton did not express any criticism of the AstraZeneca vaccine, which he instead defined as "a very interesting and very good vaccine", especially "for the logistical conditions and temperatures" at which it can be stored. now, however, Breton stressed, "we have started with Pfizer to work with the second phase and second generation vaccines".